Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective

Journal of Chemical Neuroanatomy

Volumn 41, Issue 4, 2011, Pages 234-246

  McDevitt, Ross A ^a   Neumaier, John F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT1A; 5 HT1B; Autoregulation; Serotonergic

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AUTORECEPTOR; ESTROGEN; NEUROTRANSMITTER; POTASSIUM CHANNEL; PROGESTERONE; SEROTONIN 1 AGONIST; SEROTONIN 1 RECEPTOR; SEROTONIN 1A AUTORECEPTOR; SEROTONIN 1B AUTORECEPTOR; SEROTONIN 1D AUTORECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN TRANSPORTER; TESTOSTERONE; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ANXIETY; BEHAVIORAL STRESS; BRAIN ELECTROPHYSIOLOGY; CELL ACTIVITY; DORSAL RAPHE NUCLEUS; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; ESTROGEN ACTIVITY; FEAR; FEEDBACK SYSTEM; FORCED SWIMMING TEST; GENETIC CODE; HELPLESSNESS; HORMONE ACTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEUROANATOMY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; REVIEW; REWARD; SEROTONIN RELEASE; STRESS; WAKEFULNESS;

ANIMALS; AUTORECEPTORS; EMOTIONS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NEURONS; PRESYNAPTIC TERMINALS; RAPHE NUCLEI; RATS; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; STRESS, PHYSIOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 79960087286     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.05.001     Document Type: Review

References (226)

1. Abumaria N., Rygula R., Havemann-Reinecke U., Ruther E., Bodemer W., Roos C., Flugge G. Identification of genes regulated by chronic social stress in the rat dorsal raphe nucleus. Cell. Mol. Neurobiol. 2006, 26:145-162.
2. Alves S.E., Weiland N.G., Hayashi S., McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 1998, 391:322-334.
3. Amat J., Matus-Amat P., Watkins L.R., Maier S.F. Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Res. 1998, 812:113-120.
4. Amat J., Matus-Amat P., Watkins L.R., Maier S.F. Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat. Brain Res. 1998, 797:12-22.
5. Anthony J.P., Sexton T.J., Neumaier J.F. Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J. Neurosci. Res. 2000, 61:82-87.
6. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., Mann J.J. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
7. Ase A.R., Reader T.A., Hen R., Riad M., Descarries L. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice. J. Neurochem. 2000, 75:2415-2426.
8. Ase A.R., Reader T.A., Hen R., Riad M., Descarries L. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 2001, 78:619-630.
9. Bambico F.R., Nguyen N.T., Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur. Neuropsychopharmacol. 2009, 19:215-228.
10. Baratta M.V., Christianson J.P., Gomez D.M., Zarza C.M., Amat J., Masini C.V., Watkins L.R., Maier S.F. Controllable versus uncontrollable stressors bi-directionally modulate conditioned but not innate fear. Neuroscience 2007, 146:1495-1503.
11. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
12. Bayliss D.A., Li Y.W., Talley E.M. Effects of serotonin on caudal raphe neurons: activation of an inwardly rectifying potassium conductance. J. Neurophysiol. 1997, 77:1349-1361.
13. Beck S.G., Pan Y.Z., Akanwa A.C., Kirby L.G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 2004, 91:994-1005.
14. Berendsen H.H., Broekkamp C.L. Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure. Eur. J. Pharmacol. 1994, 253:83-89.
15. Bethea C.L., Pecins-Thompson M., Schutzer W.E., Gundlah C., Lu Z.N. Ovarian steroids and serotonin neural function. Mol. Neurobiol. 1998, 18:87-123.
16. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 2004, 9:386-392.
17. Bland S.T., Hargrave D., Pepin J.L., Amat J., Watkins L.R., Maier S.F. Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology 2003, 28:1589-1596.
18. Bland S.T., Twining C., Watkins L.R., Maier S.F. Stressor controllability modulates stress-induced serotonin but not dopamine efflux in the nucleus accumbens shell. Synapse 2003, 49:206-208.
19. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 2003, 13:57-66.
20. Blier P., Chaput Y., de Montigny C. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1988, 337:246-254.
21. Blier P., De Montigny C. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J. Neurosci. 1983, 3:1270-1278.
22. Blier P., de Montigny C., Tardif D. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology (Berl.) 1984, 84:242-249.
23. Blier P., Steinberg S., Chaput Y., de Montigny C. Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus. Can. J. Physiol. Pharmacol. 1989, 67:98-105.
24. Blier P., Lista A., De Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J. Pharmacol. Exp. Ther. 1993, 265:7-15.
25. Bolanos-Jimenez F., Manhaes de Castro R.M., Seguin L., Cloez-Tayarani I., Monneret V., Drieu K., Fillion G. Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur. J. Pharmacol. 1995, 294:531-540.
26. Boldrini M., Underwood M.D., Mann J.J., Arango V. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J. Psychiatr. Res. 2008, 42:433-442.
27. Bonvento G., Scatton B., Claustre Y., Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 1992, 137:101-104.
28. Bosker F.J., Klompmakers A.A., Westenberg H.G. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 1995, 34:501-508.
29. Boureau Y.L., Dayan P. Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 2011, 36:74-97.
30. Bouwknecht J.A., Spiga F., Staub D.R., Hale M.W., Shekhar A., Lowry C.A. Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res. Bull. 2007, 72:32-43.
31. Briones-Aranda A., Rocha L., Picazo O. Influence of forced swimming stress on 5-HT1A receptors and serotonin levels in mouse brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:275-281.
32. Bruinvels A.T., Landwehrmeyer B., Gustafson E.L., Durkin M.M., Mengod G., Branchek T.A., Hoyer D., Palacios J.M. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 1994, 33:367-386.
33. Bruinvels A.T., Palacios J.M., Hoyer D. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 347:569-582.
34. Brunner D., Buhot M.C., Hen R., Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav. Neurosci. 1999, 113:587-601.
35. Buresova O., Bures J. Conditioned taste aversion induced in rats by intracerebral or systemic administration of monoamine oxidase inhibitors. Psychopharmacology (Berl.) 1987, 91:209-212.
36. Burghardt N.S., Bush D.E., McEwen B.S., LeDoux J.E. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol. Psychiatry 2007, 62:1111-1118.
37. Castanon N., Scearce-Levie K., Lucas J.J., Rocha B., Hen R. Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav. 2000, 67:559-566.
38. Castro M.E., Diaz A., del Olmo E., Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 2003, 44:93-101.
39. Cervo L., Rozio M., Ekalle-Soppo C.B., Carnovali F., Santangelo E., Samanin R. Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats. Psychopharmacology (Berl.) 2002, 163:142-150.
40. Chalmers D.T., Watson S.J. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 1991, 561:51-60.
41. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1986, 333:342-348.
42. Chen L., Salinas G.D., Li X. Regulation of serotonin 1B receptor by glycogen synthase kinase-3. Mol. Pharmacol. 2009, 76:1150-1161.
43. Christianson J.P., Paul E.D., Irani M., Thompson B.M., Kubala K.H., Yirmiya R., Watkins L.R., Maier S.F. The role of prior stressor controllability and the dorsal raphe nucleus in sucrose preference and social exploration. Behav. Brain Res. 2008, 193:87-93.
44. Christianson J.P., Ragole T., Amat J., Greenwood B.N., Strong P.V., Paul E.D., Fleshner M., Watkins L.R., Maier S.F. 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol. Psychiatry 2010, 67:339-345.
45. Clark M.S., McDevitt R.A., Hoplight B.J., Neumaier J.F. Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe. Neuroscience 2007, 146:1888-1905.
46. Clark M.S., McDevitt R.A., Neumaier J.F. Quantitative mapping of tryptophan hydroxylase-2, 5-HT1A, 5-HT1B, and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei. J. Comp. Neurol. 2006, 498:611-623.
47. Clark M.S., Sexton T.J., McClain M., Root D., Kohen R., Neumaier J.F. Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. J. Neurosci. 2002, 22:4550-4562.
48. Clark M.S., Vincow E.S., Sexton T.J., Neumaier J.F. Increased expression of 5-HT1B receptor in dorsal raphe nucleus decreases fear-potentiated startle in a stress dependent manner. Brain Res. 2004, 1007:86-97.
49. Cole J.C., Sumnall H.R. The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci. Biobehav. Rev. 2003, 27:199-217.
50. Commons K.G. Evidence for topographically organized endogenous 5-HT-1A receptor-dependent feedback inhibition of the ascending serotonin system. Eur. J. Neurosci. 2008, 27:2611-2618.
51. Compan V., Segu L., Buhot M.C., Daszuta A. Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res. 1998, 793:103-111.
52. Cools R., Nakamura K., Daw N.D. Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology 2011, 36:98-113.
53. Cooper M.A., Grober M.S., Nicholas C.R., Huhman K.L. Aggressive encounters alter the activation of serotonergic neurons and the expression of 5-HT1A mRNA in the hamster dorsal raphe nucleus. Neuroscience 2009, 161:680-690.
54. Cooper M.A., McIntyre K.E., Huhman K.L. Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat. Psychoneuroendocrinology 2008, 33:1236-1247.
55. Cornelisse L.N., Van der Harst J.E., Lodder J.C., Baarendse P.J., Timmerman A.J., Mansvelder H.D., Spruijt B.M., Brussaard A.B. Reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats. J. Neurophysiol. 2007, 98:196-204.
56. Cremers T.I., Spoelstra E.N., de Boer P., Bosker F.J., Mork A., den Boer J.A., Westerink B.H., Wikstrom H.V. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. Eur. J. Pharmacol. 2000, 397:351-357.
57. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29:547-569.
58. Davidson C., Stamford J.A. Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus. Neurochem. Int. 2000, 36:91-96.
59. Daw N.D., Kakade S., Dayan P. Opponent interactions between serotonin and dopamine. Neural Network 2002, 15:603-616.
60. Daws L.C., Gould G.G., Teicher S.D., Gerhardt G.A., Frazer A. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J. Neurochem. 2000, 75:2113-2122.
61. Dawson L.A., Nguyen H.Q., Smith D.L., Schechter L.E. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J. Psychopharmacol. 2002, 16:145-152.
62. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 2004, 474:364-378.
63. De Almeida R.M., Giovenardi M., Charchat H., Lucion A.B. 8-OH-DPAT in the median raphe nucleus decreases while in the medial septal area it may increase anxiety in female rats. Neurosci. Biobehav. Rev. 1998, 23:259-264.
64. De Vry J., Eckel G., Kuhl E., Schreiber R. Effects of serotonin 5-HT(1) and 5-HT(2) receptor agonists in a conditioned taste aversion paradigm in the rat. Pharmacol. Biochem. Behav. 2000, 66:797-802.
65. Dekeyne A., Denorme B., Monneyron S., Millan M.J. Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology 2000, 39:1114-1117.
66. Doly S., Valjent E., Setola V., Callebert J., Herve D., Launay J.M., Maroteaux L. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J. Neurosci. 2008, 28:2933-2940.
67. Doly S., Bertran-Gonzalez J., Callebert J., Bruneau A., Banas S.M., Belmer A., Boutourlinsky K., Herve D., Launay J.M., Maroteaux L. Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS One 2009, 4:e7952.
68. Doucet E., Pohl M., Fattaccini C.M., Adrien J., Mestikawy S.E., Hamon M. In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 1995, 19:18-28.
69. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 1999, 46:1375-1387.
70. el Mansari M., Bouchard C., Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology 1995, 13:117-127.
71. File S.E., Gonzalez L.E., Andrews N. Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 1996, 16:4810-4815.
72. Fletcher P.J., Ming Z.H., Higgins G.A. Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus. Psychopharmacology (Berl.) 1993, 113:31-36.
73. Flugge G. Dynamics of central nervous 5-HT1A-receptors under psychosocial stress. J. Neurosci. 1995, 15:7132-7140.
74. Fu W., Le Maitre E., Fabre V., Bernard J.F., David Xu Z.Q., Hokfelt T. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J. Comp. Neurol. 2010, 518:3464-3494.
75. Gardier A.M., Guiard B.P., Guilloux J.P., Reperant C., Coudore F., David D.J. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundam. Clin. Pharmacol. 2009, 23:23-42.
76. Gommans J., Bouwknecht J.A., Hijzen T.H., Berendsen H.H., Broekkamp C.L., Maes R.A., Olivier B. Stimulus properties of fluvoxamine in a conditioned taste aversion procedure. Psychopharmacology (Berl.) 1998, 140:496-502.
77. Graeff F.G., Netto C.F., Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 1998, 23:237-246.
78. Greenwood B.N., Foley T.E., Burhans D., Maier S.F., Fleshner M. The consequences of uncontrollable stress are sensitive to duration of prior wheel running. Brain Res. 2005, 1033:164-178.
79. Greenwood B.N., Foley T.E., Day H.E., Burhans D., Brooks L., Campeau S., Fleshner M. Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol. Psychiatry 2005, 57:559-568.
80. Griebel G., Moreau J.L., Jenck F., Misslin R., Martin J.R. Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl.) 1994, 113:463-470.
81. Gross C., Santarelli L., Brunner D., Zhuang X., Hen R. Altered fear circuits in 5-HT(1A) receptor KO mice. Biol. Psychiatry 2000, 48:1157-1163.
82. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
83. Gudelsky G.A., Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 2008, 90:198-207.
84. Gundlach A.L., Wisden W., Morris B.J., Hunt S.P. Localization of preprogalanin mRNA in rat brain: in situ hybridization study with a synthetic oligonucleotide probe. Neurosci. Lett. 1990, 114:241-247.
85. Haleem D.J. Attenuation of 8-OH-DPAT-induced decreases in 5-Ht synthesis in brain regions of rats adapted to a repeated stress schedule. Stress 1999, 3:123-129.
86. Hammack S.E., Richey K.J., Schmid M.J., LoPresti M.L., Watkins L.R., Maier S.F. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J. Neurosci. 2002, 22:1020-1026.
87. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behav. Brain Res. 2008, 195:198-213.
88. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15049-15054.
89. Hensler J.G. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 2002, 26:565-573.
90. Higgins G.A., Bradbury A.J., Jones B.J., Oakley N.R. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology 1988, 27:993-1001.
91. Higgins G.A., Jones B.J., Oakley N.R. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology (Berl.) 1992, 106:261-267.
92. Hiroi R., Neumaier J.F. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav. Brain Res. 2006, 166:93-100.
93. Hiroi R., Neumaier J.F. Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field. Neuroscience 2009, 158:456-464.
94. Hjorth S., Bengtsson H.J., Kullberg A., Carlzon D., Peilot H., Auerbach S.B. Serotonin autoreceptor function and antidepressant drug action. J. Psychopharmacol. 2000, 14:177-185.
95. Hjorth S., Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 1988, 338:463-471.
96. Hjorth S., Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 1991, 48:1779-1786.
97. Hjorth S., Suchowski C.S., Galloway M.P. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse 1995, 19:170-176.
98. Hjorth S., Tao R. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur. J. Pharmacol. 1991, 209:249-252.
99. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology 1994, 33:343-348.
100. Holmes A., Picciotto M.R. Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction?. CNS Neurol. Disord. Drug Targets 2006, 5:225-232.
101. Holmes P.V. Rodent models of depression: reexamining validity without anthropomorphic inference. Crit. Rev. Neurobiol. 2003, 15:143-174.
102. Hoyer D., Middlemiss D.N. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 1989, 10:130-132.
103. Hutson P.H., Sarna G.S., O'Connell M.T., Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett. 1989, 100:276-280.
104. Innis R.B., Aghajanian G.K. Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. Eur. J. Pharmacol. 1987, 143:195-204.
105. Invernizzi R., Bramante M., Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur. J. Pharmacol. 1994, 260:243-246.
106. Ischia R., Lovisetti-Scamihorn P., Hogue-Angeletti R., Wolkersdorfer M., Winkler H., Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J. Biol. Chem. 1997, 272:11657-11662.
107. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
108. Janoshazi A., Deraet M., Callebert J., Setola V., Guenther S., Saubamea B., Manivet P., Launay J.M., Maroteaux L. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors. Mol. Pharmacol. 2007, 71:1463-1474.
109. Jolas T., Haj-Dahmane S., Kidd E.J., Langlois X., Lanfumey L., Fattaccini C.M., Vantalon V., Laporte A.M., Adrien J., Gozlan H., et al. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther. 1994, 268:1432-1443.
110. Jongsma M.E., Bosker F.J., Cremers T.I., Westerink B.H., den Boer J.A. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:738-744.
111. Kaiyala K.J., Vincow E.S., Sexton T.J., Neumaier J.F. 5-HT1B receptor mRNA levels in dorsal raphe nucleus: inverse association with anxiety behavior in the elevated plus maze. Pharmacol. Biochem. Behav. 2003, 75:769-776.
112. Kalivas P.W., Duffy P., White S.R. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 1998, 18:469-479.
113. Katayama J., Yakushiji T., Akaike N. Characterization of the K+ current mediated by 5-HT1A receptor in the acutely dissociated rat dorsal raphe neurons. Brain Res. 1997, 745:283-292.
114. Kennett G.A., Marcou M., Dourish C.T., Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 1987, 138:53-60.
115. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 1995, 682:189-196.
116. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J. Pharmacol. Exp. Ther. 1997, 282:967-976.
117. Kirby L.G., Pan Y.Z., Freeman-Daniels E., Rani S., Nunan J.D., Akanwa A., Beck S.G. Cellular effects of swim stress in the dorsal raphe nucleus. Psychoneuroendocrinology 2007, 32:712-723.
118. Korte S.M., Buwalda B., Meijer O., De Kloet E.R., Bohus B. Socially defeated male rats display a blunted adrenocortical response to a low dose of 8-OH-DPAT. Eur. J. Pharmacol. 1995, 272:45-50.
119. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 1995, 274:866-876.
120. Laaris N., Le Poul E., Hamon M., Lanfumey L. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus - in vitro electrophysiological evidence. Fundam. Clin. Pharmacol. 1997, 11:206-214.
121. Lanfumey L., Pardon M.C., Laaris N., Joubert C., Hanoun N., Hamon M., Cohen-Salmon C. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 1999, 10:3369-3374.
122. Langlois X., Gerard C., Darmon M., Chauveau J., Hamon M., el Mestikawy S. Immunolabeling of central serotonin 5-HT1D beta receptors in the rat, mouse, and guinea pig with a specific anti-peptide antiserum. J. Neurochem. 1995, 65:2671-2681.
123. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol. Psychiatry 2007, 61:1081-1089.
124. Launay J.M., Schneider B., Loric S., Da Prada M., Kellermann O. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. Faseb J. 2006, 20:1843-1854.
125. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 352:141-148.
126. Le Saux M., Di Paolo T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J. Psychiatr. Neurosci. 2005, 30:110-117.
127. Lemos J.C., Phillips P.E., Chavkin C.C. Stress-Induced Dysregulation of Kappa Opioid Modulation of Serotonergic DRN Neuronal Excitability 2010, Society for Neuroscience Annual Meeting, San Diego, CA.
128. Leventopoulos M., Russig H., Feldon J., Pryce C.R., Opacka-Juffry J. Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine. Neuropharmacology 2009, 56:692-701.
129. Lin D., Parsons L.H. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze. Pharmacol. Biochem. Behav. 2002, 71:581-587.
130. Lin S.L., Setya S., Johnson-Farley N.N., Cowen D.S. Differential coupling of 5-HT(1) receptors to G proteins of the G(i) family. Br. J. Pharmacol. 2002, 136:1072-1078.
131. Lu N.Z., Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
132. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 1998, 44:151-162.
133. Maier S.F. Role of fear in mediating shuttle escape learning deficit produced by inescapable shock. J. Exp. Psychol. Anim. Behav. Process 1990, 16:137-149.
134. Maier S.F., Grahn R.E., Watkins L.R. 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. Behav. Neurosci. 1995, 109:404-412.
135. Maier S.F., Ryan S.M., Barksdale C.M., Kalin N.H. Stressor controllability and the pituitary-adrenal system. Behav. Neurosci. 1986, 100:669-674.
136. Maier S.F., Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 2005, 29:829-841.
137. Malleret G., Hen R., Guillou J.L., Segu L., Buhot M.C. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J. Neurosci. 1999, 19:6157-6168.
138. Manrique C., Segu L., Hery F., Hery M., Faudon M., Francois-Bellan A.M. Increase of central 5-HT1B binding sites following 5,7-dihydroxytryptamine axotomy in the adult rat. Brain Res. 1993, 623:345-348.
139. Marrow L.P., Overton P.G., Brain P.F. A re-evaluation of social defeat as an animal model of depression. J. Psychopharmacol. 1999, 13:115-121.
140. Martin P., Soubrie P., Puech A.J. Reversal of helpless behavior by serotonin uptake blockers in rats. Psychopharmacology (Berl.) 1990, 101:403-407.
141. Massot O., Rousselle J.C., Grimaldi B., Cloez-Tayarani I., Fillion M.P., Plantefol M., Bonnin A., Prudhomme N., Fillion G. Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype. Ann. N. Y. Acad. Sci. 1998, 861:174-182.
142. Maswood S., Barter J.E., Watkins L.R., Maier S.F. Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Brain Res. 1998, 783:115-120.
143. Matto V., Harro J., Allikmets L. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat. J. Physiol. Pharmacol. 1996, 47:661-669.
144. Maura G., Raiteri M. Functional evidence that chronic drugs induce adaptive changes of central autoreceptors regulating serotonin release. Eur. J. Pharmacol. 1984, 97:309-313.
145. McDevitt R.A., Hiroi R., Mackenzie S.M., Robin N.C., Cohn A., Kim J.J., Neumaier J.F. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol. Psychiatry 2011, 69:780-787.
146. McDevitt R.A., Szot P., Baratta M.V., Bland S.T., White S.S., Maier S.F., Neumaier J.F. Stress-induced activity in the locus coeruleus is not sensitive to stressor controllability. Brain Res. 2009, 1285:109-118.
147. Melander T., Hokfelt T., Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J. Comp. Neurol. 1986, 248:475-517.
148. Melander T., Kohler C., Nilsson S., Hokfelt T., Brodin E., Theodorsson E., Bartfai T. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Chem. Neuroanat. 1988, 1:213-233.
149. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
150. Metcalf M.A., McGuffin R.W., Hamblin M.W. Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis. Biochem. Pharmacol. 1992, 44:1917-1920.
151. Millan M.J., Marin P., Bockaert J., Mannoury la Cour C. Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol. Sci. 2008, 29:454-464.
152. Miquel M.C., Doucet E., Riad M., Adrien J., Verge D., Hamon M. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. Brain Res. Mol. Brain Res. 1992, 14:357-362.
153. Mir S., Taylor D. The adverse effects of antidepressants. Curr. Opin. Psychiatr. 1997, 10:88-94.
154. Moret C., Briley M. Serotonin autoreceptor subsensitivity and antidepressant activity. Eur. J. Pharmacol. 1990, 180:351-356.
155. Moret C., Briley M. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 1996, 295:189-197.
156. Morgan M.A., Schulkin J., Pfaff D.W. Estrogens and non-reproductive behaviors related to activity and fear. Neurosci. Biobehav. Rev. 2004, 28:55-63.
157. Neumaier J.F., Edwards E., Plotsky P.M. 5-HT(1B) mrna regulation in two animal models of altered stress reactivity. Biol. Psychiatry 2002, 51:902-908.
158. Neumaier J.F., Petty F., Kramer G.L., Szot P., Hamblin M.W. Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus. Biol. Psychiatry 1997, 41:668-674.
159. Neumaier J.F., Root D.C., Hamblin M.W. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 1996, 15:515-522.
160. Neumaier J.F., Szot P., Peskind E.R., Dorsa D.M., Hamblin M.W. Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain. Brain Res. 1996, 722:50-58.
161. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., Eckelman W., Herscovitch P., Charney D.S., Drevets W.C. Reduced serotonin type 1A receptor binding in panic disorder. J. Neurosci. 2004, 24:589-591.
162. Newman M.E., Lerer B., Shapira B. 5-HT-1A receptor-mediated effects of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 1993, 17:1-19.
163. O'Connor J.J., Kruk Z.L. Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro. Brain Res. 1994, 640:328-335.
164. Offord S.J., Ordway G.A., Frazer A. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat. J. Pharmacol. Exp. Ther. 1988, 244:144-153.
165. Ogren S.O., Razani H., Elvander-Tottie E., Kehr J. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders. Physiol. Behav. 2007, 92:172-179.
166. Oksenberg D., Marsters S.A., O'Dowd B.F., Jin H., Havlik S., Peroutka S.J., Ashkenazi A. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature 1992, 360:161-163.
167. Olivier B., Gommans J., van der Gugten J., Bouwknecht J.A., Herremans A.H., Patty T., Hijzen T.H. Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures. Pharmacol. Biochem. Behav. 1999, 64:213-220.
168. Papp M., Willner P. 8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists. Psychopharmacology (Berl.) 1991, 103:99-102.
169. Pare W.P., Tejani-Butt S.M. Effect of stress on the behavior and 5-HT system in Sprague-Dawley and Wistar Kyoto rat strains. Integr. Physiol. Behav. Sci. 1996, 31:112-121.
170. Parker E.M., Grisel D.A., Iben L.G., Shapiro R.A. A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors. J. Neurochem. 1993, 60:380-383.
171. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10734-10739.
172. Parsey R.V., Olvet D.M., Oquendo M.A., Huang Y.Y., Ogden R.T., Mann J.J. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 2006, 31:1745-1749.
173. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney, Orlando. 2nd edn.
174. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 1985, 346:205-230.
175. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89:267-277.
176. Pejchal T., Foley M.A., Kosofsky B.E., Waeber C. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br. J. Pharmacol. 2002, 135:1115-1122.
177. Penington N.J., Kelly J.S., Fox A.P. Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT1A receptors on dorsal raphe neurones of the adult rat. J. Physiol. 1993, 469:387-405.
178. Petty F., Kramer G., Wilson L., Jordan S. In vivo serotonin release and learned helplessness. Psychiatr. Res. 1994, 52:285-293.
179. Picazo O., Lopez-Rubalcava C., Fernandez-Guasti A. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res. Bull. 1995, 37:169-175.
180. Pineyro G., Blier P. Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration. J. Pharmacol. Exp. Ther. 1996, 276:697-707.
181. Pineyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 1999, 51:533-591.
182. Pineyro G., Castanon N., Hen R., Blier P. Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice. Neuroreport 1995, 7:353-359.
183. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 1992, 12:440-453.
184. Pranzatelli M.R., Durkin M.M., Farmer M. Plastic responses of neonatal 5-hydroxytryptamine1B receptors to 5,7-dihydroxytryptamine lesions mapped by quantitative autoradiography. Int. J. Dev. Neurosci. 1996, 14:621-629.
185. Prendergast M.A., Hendricks S.E., Yells D.P., Balogh S. Conditioned taste aversion induced by fluoxetine. Physiol. Behav. 1996, 60:311-315.
186. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14476-14481.
187. Rau V., Fanselow M.S. Exposure to a stressor produces a long lasting enhancement of fear learning in rats. Stress 2009, 12:125-133.
188. Razzoli M., Carboni L., Andreoli M., Michielin F., Ballottari A., Arban R. Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacol. Biochem. Behav. 2011, 97:566-576.
189. Remy S.M., Schreiber R., Dalmus M., De Vry J. Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology (Berl.) 1996, 125:89-91.
190. Riad M., Garcia S., Watkins K.C., Jodoin N., Doucet E., Langlois X., el Mestikawy S., Hamon M., Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 2000, 417:181-194.
191. Riad M., Rbah L., Verdurand M., Aznavour N., Zimmer L., Descarries L. Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 2008, 151:692-700.
192. Riad M., Watkins K.C., Doucet E., Hamon M., Descarries L. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci. 2001, 21:8378-8386.
193. Richardson-Jones J.W., Craige C.P., Guiard B.P., Stephen A., Metzger K.L., Kung H.F., Gardier A.M., Dranovsky A., David D.J., Beck S.G., Hen R., Leonardo E.D. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
194. Riegert C., Rothmaier A.K., Leemhuis J., Sexton T.J., Neumaier J.F., Cassel J.C., Jackisch R. Increased expression of 5-HT(1B) receptors by Herpes simplex virus gene transfer in septal neurons: New in vitro and in vivo models to study 5-HT(1B) receptor function. Brain Res. Bull. 2008, 76:439-453.
195. Romaniuk A., Koprowska M., Krotewicz M., Strzelczuk M., Wieczorek M. Effects of 8-OHDPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats. Behav. Brain Res. 2001, 120:47-57.
196. Rozeske R.R., Watkins L.R., Lowry C.A., Maier S.F. The role of the medial prefrontal cortex in dorsal raphe nucleus 5-HT1A receptor adaptation following escapable and inescapable stress. Society for Neuroscience Annual Meeting 2010.
197. Rueter L.E., Fornal C.A., Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev. Neurosci. 1997, 8:117-137.
198. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?. Psychopharmacology (Berl.) 1997, 129:197-205.
199. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., Cowen P.J. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatr. 2000, 57:174-180.
200. Sarhan H., Fillion G. Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 360:382-390.
201. Sari Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 2004, 28:565-582.
202. Sari Y., Lefevre K., Bancila M., Quignon M., Miquel M.C., Langlois X., Hamon M., Verge D. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res. 1997, 760:281-286.
203. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., Verge D. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 1999, 88:899-915.
204. Sayer T.J., Hannon S.D., Redfern P.H., Martin K.F. Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment. Br. J. Pharmacol. 1999, 126:1777-1784.
205. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatr. 1965, 122:509-522.
206. Schreiber R., De Vry J. Neuroanatomical basis for the antidepressant-like effects of the 5-HT(1A) receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav. Pharmacol. 1993, 4:625-636.
207. Sexton T.J., McEvoy C., Neumaier J.F. (+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain. Mol. Psychiatr. 1999, 4:572-579.
208. Shen C., Li H., Meller E. Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology 2002, 42:1031-1038.
209. Sijbesma H., Schipper J., de Kloet E.R., Mos J., van Aken H., Olivier B. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol. Biochem. Behav. 1991, 38:447-458.
210. Sotelo C., Cholley B., El Mestikawy S., Gozlan H., Hamon M. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 1990, 2:1144-1154.
211. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf. 1999, 20:277-287.
212. Sprouse J.S., Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 1988, 27:707-715.
213. Stamford J.A., Davidson C., McLaughlin D.P., Hopwood S.E. Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci. 2000, 23:459-465.
214. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 1998, 18:7394-7401.
215. Subhan F., Deslandes P.N., Pache D.M., Sewell R.D. Do antidepressants affect motivation in conditioned place preference?. Eur. J. Pharmacol. 2000, 408:257-263.
216. Sumner B.E., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol. Cell Neurosci. 1993, 4:83-92.
217. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
218. Trillat A.C., Malagie I., Scearce K., Pons D., Anmella M.C., Jacquot C., Hen R., Gardier A.M. Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. J. Neurochem. 1997, 69:2019-2025.
219. Valdizan E.M., Castro E., Pazos A. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. Int. J. Neuropsychopharmacol. 2010, 13:835-843.
220. Vanderhorst V.G., Gustafsson J.A., Ulfhake B. Estrogen receptor-alpha and -beta immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems. J. Comp. Neurol. 2005, 488:152-179.
221. Verge D., Daval G., Marcinkiewicz M., Patey A., el Mestikawy S., Gozlan H., Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 1986, 6:3474-3482.
222. Voigt M.M., Laurie D.J., Seeburg P.H., Bach A. Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. Embo J. 1991, 10:4017-4023.
223. Waeber C., Dietl M.M., Hoyer D., Palacios J.M. 5HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn Schmiedebergs Arch. Pharmacol. 1989, 340:486-494.
224. Waselus M., Galvez J.P., Valentino R.J., Van Bockstaele E.J. Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum. J. Chem. Neuroanat. 2006, 31:233-242.
225. Will M.J., Der-Avakian A., Bland S.T., Grahn R.E., Hammack S.E., Sparks P.D., Pepin J.L., Watkins L.R., Maier S.F. Electrolytic lesions and pharmacological inhibition of the dorsal raphe nucleus prevent stressor potentiation of morphine conditioned place preference in rats. Psychopharmacology (Berl.) 2004, 171:191-198.
226. Zhang L., Ma W., Barker J.L., Rubinow D.R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 1999, 94:251-259.